Introduction {#sec1-1}
============

Plants have been used for medicinal purposes since time immemorial. In recent years, there is strong current interest in discovering new edible natural products with medicinal properties. It has been estimated by WHO (World Health Organization) (2002) that about 90% of the world's population from developing countries rely mainly on traditional medicines (mostly derived from plants) for their primary health care. In Morocco, the use of traditional medicine is widespread practice, the use of plants in the form of infusions or decoctions is a common practice among people of rural communities and their use is increasing in urban populations (Gonzalez-Tejero *et al.*, 2008). The ethnobotanical and ethnopharmacological surveys conducted in different areas allowed the compilation of an inventory of 360 species and more than 500 prescriptions are recorded (Bellakhdar, 1997).

The genus Ormenis which includes *Ormenis eriolepis Coss* (Asteraceae) an endemic Moroccan subspecies, traditionally named "Hellala" or "Fergoga". It's usually used for its hypoglycemic effect as well as for the treatment of stomacal pain. Traditionally the inflorescences of this plant are mixed with honey and used for the treatment of the cardialgia ulcer and stomacal pain.

The ability of chemotherapeutic agents to induce apoptosis in tumor cells has become a therapeutic approach which may be enhanced by the development of novel approaches during treatment (Gibb *et al.*, 1997). Evidence from various studies suggests that metabolites derived from plants may possess pro-apoptotic properties and have great potential for possible applications in cancer prevention (Moongkarndi *et al.*, 2004; Kwon *et al.*, 2006; *Prasanna et al.*, 2009; Radhika *et al.*, 2010; Choedon *et al.*, 2010).

Apoptosis is characterized by particular morphological changes, including plasma membrane bleb, cell shrinkage, depolarization of mitochondria, chromatin condensation, DNA fragmentation and cell cycle arrest that can be triggered by damage on DNA (Ben-Porath and Weinberg, 2005; Maruyama *et al.*, 2009).

The p-H2AX has been considered the main signaling protein involved in the response to DNA damage playing an important role in DNA repair (Yuan *et al.*, 2010).

The relationship between apoptosis and cell cycle arrest has been a recent focus. Apoptosis provides a number of useful clues when generating effective therapies and many chemotherapeutic agents exert their anticancer effects by inducing apoptosis and/or cell cycle arrest in cancer cells (Schuchmann and Galle, 2004).

As far as we know, there is no scientific exploration of anti tumoral activity of *Ormenis eriolepis* extracts. In this regard, the purpose of this study was the screening of organic extracts and fractions in a panel of both hematological and solid cancer cell lines, to evaluate the potential anti tumoral activity and to elucidate the respective mechanisms that may be responsible for growth arrest and cell death induction. Finally, we suggest potential bioactive compounds responsible for these effects upon determination of chemical composition of both Oe-DF and Oe-HE by GC/MS.

Materials and Methods {#sec1-2}
=====================

Plant material {#sec2-1}
--------------

The aerial parts of *Ormenis eriolepisCoss*. (Asteraceae) were collected in 2009 from Ouarzazat (Morocco). The plant was identified at the Scientific Institute of Rabat by Prof. M. Fennane, and the specimen was deposited in the Scientific Institute herbarium.

Preparation of Extracts {#sec2-2}
-----------------------

The collected parts were air-dried and mechanically ground to produce a fine powder. 120g of plant powder was successively extracted using a Soxhlet apparatus with n-hexane (1.3L) and methanol (1.3L) to obtain hexanic extract (Oe-HE 3,91g) and methanolic extract (Oe-ME 10,94g) the resulting extracts were then evaporated by a Rotavapor to give dried extracts. The methanol concentrated extract was dissolved in distilled water and was successively extracted with dichloromethane (1.3L) and ethyl acetate (1.3L) to obtain dichloromethane fraction (Oe -DF 3,28g) and ethyl acetate fraction (Oe-AF 3,16g). All extracts were evaporated by a Rotavapor and kept at -20°C until use.

Cell culture {#sec2-3}
------------

Jurkat, Jeko-1 and TK6 cells were maintained in RPMI-1640 with L-Glutamine and HEPES (Sigma-Aldrich, St. Louis, MO). LN229, SW620, U2OS, PC-3 and NIH3T3 cells were maintained in DMEM High Glucose (4.5 g/l) with L-glutamine (Invitrogen, Carlsbad, CA). All cells were grown in a humidified incubator at 37°C with 5% CO2. RPMI and DMEM were supplemented with 10% heat inactivated foetal bovine serum and 100 units/ml penicillin/streptomycin (Sigma-Aldrich, St. Louis, MO). All cell lines were subconfluently grown and passaged, routinely tested for mycoplasma contamination and subjected to frequent morphological tests and growth curve analysis as quality-control assessments. All cell lines were treated at a prophylactic concentration of 5 μg/ml Plasmocin™ (InvivoGen, San Diego, CA).

Drugs and inhibitors {#sec2-4}
--------------------

SP600125, U0126, H1152, Pifithrin α and JAK3 inhibitor I (Calbiochem, Darmstadt, Germany) were added directly to the media at the indicated concentration and cells were harvested or analyzed at the time points indicated in the figure legends.

Cell viability assays {#sec2-5}
---------------------

The number of viable cells in culture was determined based on quantification of ATP, which signals the presence of metabolically-active cells, using the Cell Titer-Glo luminiscent assay kit (Promega, Madison, WI, USA). Following the manufacturer's instructions, the cells were plated in 96-well plates, treated 24 h later with extracts dissolved in DMSO for the indicated times and concentrations, followed by addition of Cell Titer-Glo reagent. Luminiscence was detected using a multi-well Synergy Mx scanning spectrophotometer (Biotek, Winooski, VT).

Cell cycle analysis {#sec2-6}
-------------------

Cell cycle analysis was performed using propidium iodide staining. Briefly, cells were washed in phosphate-buffered saline (PBS) and fixed in 70% ethanol. Fixed cells were then washed twice in PBS and stained in propidium iodide (50 g/ml) in the presence of 50 g/ml RNase A (Sigma-Aldrich, St Louis, MO, USA), then analysed by flow cytometry using a FACScan (Coulter Epics XL-MSL; Beckman Coulter, Fullerton, CA, USA) and winMDI software.

Annexin V-FITC/propidium iodide flow cytometric analysis {#sec2-7}
--------------------------------------------------------

Analysis of phosphatidylserine externalization in apoptotic cells was determined by an ApoTarget Annexin-V-FITC Apoptosis kit (Invitrogen), according to the manufacturer's instructions. 2 x 10^5^ cells were seeded in 6-well plates and treated with 50μg/ml of Mv-DF for 48h. They were then collected and suspended in 100μl of Annexin V-binding buffer. 5μL of Annexin-V-FITC and 1O-β of propidium iodide were added and incubated 15 min at room temperature in the dark. Flow cytometry analysis was carried out using a FACScan (Coulter Epics XL-MSL; Beckman Coulter, Fullerton, CA, USA) and winMDI software.

Caspase activity analysis {#sec2-8}
-------------------------

Enzymatic activity of caspases was determined by measurement of caspases-3 and 7 activity by means of the luminometric Caspase-Glo 3/7 assay (Promega) according to the manufacturer's protocol using a Synergy HT multi-detection microplate reader (Bio-Tek, Winooski, VT, USA).

Gel electrophoresis and immunoblotting {#sec2-9}
--------------------------------------

Cells were harvested in a buffer containing 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA and 1% (v/v) Triton X-100 plus protease and phosphatase inhibitors. Protein content was measured by the Bradford procedure. Cell lysates were electrophoresed in SDS-polyacrylamide gels. After electrophoresis, the proteins were transferred to Immobilon-P strips (Millipore, Billerica, MA) for 2 h at 60 V. The sheets were pre-incubated in TBS (20 mM Tris-HCl pH 7.5, 150 mM NaCl), 0.05% Tween 20 and 5% defatted milk powder for 1 h at room temperature and then incubated for 1 h at room temperature in TBS, 0.05% Tween 20, 1% BSA and 0.5% defatted milk powder containing the appropriate antibodies: pH2A.X (\#9718, 1:1000) and β-tubulin (T0198, Sigma-Aldrich, St. Louis, MO, 1:4000). After washing in TBS, 0.05% Tween 20, the sheets were incubated with a peroxidase-coupled secondary antibody (Dako, Glostrup, Denmark, 1/2000 dilution,) for 1 h at room temperature. After incubation, the sheets were washed twice in TBS, 0.05% Tween 20 and once in TBS. The peroxidase reaction was visualized by the enhanced chemiluminiscence detection system (Millipore, Billerica, MA).

Derivatizations for GC/MS analysis {#sec2-10}
----------------------------------

For this purpose, 100μl of the extracts were dried with N2 gas, then 100μl of derivatization agent (N, O-bis (trimethylsilyl) trifluoroacetamide with 1% of trimethylchlorosilane) was added, mixed and heated 10 minutes at 60°C.

Gas chromatography/mass spectrometry (GC/MS) analysis {#sec2-11}
-----------------------------------------------------

The GC-MS analyses of *Ormenis eriolepis* Dichloromethane Fraction (Oe-DF) and Hexanic Extract (Oe-HE) were carried out at the Instrumental Technical Services of the "Estación Experimental del Zaidín" (CSIC, Granada, Spain). Briefly, 1 μl of the derivative solution was injected in a Varian 450GC coupled to 240 Ion Trap Mass Spectrometer as detector. The injection conditions were: splitless mode with 1 minute duration pulse, the injector temperature was 250°C; the He column flow was 1 ml/minute in a capillary column (Varian Factor Four VF-5 ms 30mx0.25mmx0.25 pm). For Mass spectrometry conditions, the EI ionization was 70 eV, the transfer line was at 280°C and the Trap at 240°C, mass range acquisition was from m/z 50 to m/z 500 and cared in Full Scan mode. Qualitative analysis of compounds was based on the comparison of their spectral mass and their relative Retention time with those of NIST08 mass spectra database and Kovats RI on the chromatograms recorded in Full Scan or in SIM mode usin g the characteristics ions. Quantitative analysis was realized by integration of peaks and calculated as percent of total identified area on the TIC chromatograms.

Statistical Analysis {#sec2-12}
--------------------

Data are presented as means ± SD of at least three different assays performed in triplicate. IC50 value and the statistical significance of differences by Student's *t* test were assessed using GraphPad Prism (GraphPad Software Inc. La Jolla, CA). Statistically significant differences are indicated by \*\*\*P \<0.001, \*\*P \<0.01 and \*P \<0.05.

Results {#sec1-3}
=======

Analysis of the cytotoxic activity of Ormenis eriolepis organic extracts against human cancer cell lines. {#sec2-13}
---------------------------------------------------------------------------------------------------------

To investigate the potential effect of *Ormenis eriolepis* organic extracts against cancer, various hematological and solid cancer cell lines of different origin were screened. Non transformed cell lines TK-6 and NIH3T3 were also tested as control. Interestingly, both the dichloromethane fraction (Oe-DF) and the hexanic extract (Oe-HE) exhibited respectively a dramatic effect against Jurkat and Jeko-1([figure 1A](#F1){ref-type="fig"}) and LN229 and PC-3 ([figure 1B](#F1){ref-type="fig"}) cells, both extracts had no effect against normal cell lines TK-6 and NIH3T3.

![Cytotoxic activity of *Ormenis eriolepis* organic extracts and fractions in a panel of cancer and nontransformed cell lines. A. suspension cells panel Jurkat, Jeko-1, and TK-6 and **B**. adherent cells panel LN229, SW620, U2OS, PC-3 and NIH3T3; were incubated for 48 h with 50 μg/ml of each extract and fraction. Results represent the mean ±SD of at least 3 independent experiments indicating the percentage of viable cells relative to vehicle-treated (control) cells. Statistically significant differences are indicated by \*\*\*p \< 0.005 compared with untreated.](AJTCAM-14-356-g001){#F1}

In order to calculate the IC50, we next performed a dose-response (0-50μg/ml) viability assay using TK-6 as control for Jurkat and Jeko-1 and NIH3T3 for LN229 and PC-3 cells. The obtained cell growth curves in [Figure 2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"} prove that Oe-DF and Oe-HE exerts a specific dose dependant inhibitory effect on cell proliferation. The IC50 values were (11,63±5,37μg/mL) for Jurkat and (13,33±1,67μg/mL) for Jeko-1 under Oe-DF treatment and (41,67±1,98μg/mL) for LN229, (19,31±4,88μg/mL) for PC-3 cells upon treatment with Oe-HE. Both the fraction and extract exhibited no effects on TK6 and NIH3T3 respectively. Doses of 20 μg/ml of Oe-DF and 50 μg/ml of Oe-HE were chosen for further mechanistic studies in (Jurkat; jeko-1) and (LN229; PC-3) cells.

![(A) Dose-response analysis of *Ormenis eriolepis* dichloromethane fraction (Oe-DF) and IC50 determination on Jurkat and Jeko-1 cells. (B) Dose-response analysis of *Ormenis eiriolepis* hexanic extract (Oe-HE) and IC50 determination on LN229 and PC-3 cells. Cells were treated for 48h at different concentrations ranging from 1 to 50μg/ml; IC50 value (μg/ml) was determined graphically from the viability curves, NIH3T3 and TK6 cells were used as control. Data are expressed as means ±SD of triplicate determinations.](AJTCAM-14-356-g002){#F2}

In order to calculate the IC50, we next performed a dose-response (0-50μg/mL) viability assay using TK-6 as control for Jurkat and Jeko-1 and NIH3T3 for LN229 and PC-3 cells. The obtained cell growth curves in [Figure 2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"} prove that Oe-DF and Oe-HE exerts a specific dose dependant inhibitory effect on cell proliferation. The IC50 values were (11,63±5,37μg/mL) for Jurkat and (13,33±1,67μg/mL) for Jeko-1 under Oe-DF tratement and (41,67±1,98μg/mL) for LN229, (19,31±4,88μg/ml) for PC-3 cells upon treatement with Oe-HE. Both the fraction and extract exhibited no effects on TK6 and NIH3T3 respectively. Doses of 20 μg/ml of Oe-DF and 50 μg/ml of Oe-HE were chosen for further mechanistic studies in (Jurkat; jeko-1) and (LN229; PC-3) cells.

Analysis of cell cycle effect of Ormenis eriolepis organic extracts. {#sec2-14}
--------------------------------------------------------------------

In order to investigate how cell cycle distribution is affected, (jurkat; Jeko-1) were treated with a concentration of 20 μ¦/Μ of Oe-DF and (LN229; PC-3) with 50μg/ml of Oe-HE for 24 and 48h. As shown in [figure 3](#F3){ref-type="fig"} Oe-DF have effectively reduced the proportion of S-phase cells while strongly increased the proportion of Sub G1 cells (35,62% for jurkat and 64,75% for jeko-1 at 48h). Whereas Oe-HEin LN229 cells mainly exerts a combination of G1 arrest and sub-G1 increase at 24h, with this latter population further increasing at 48h up to 42%. In PC-3 cells Oe-HE induced a clear G2/M arrest which was already detectable at 24h leading at 48h to a G2/M cell population of 44.11%.

![cell cycle distribution analysis of Jurkat, Jeko-1, LN229 and PC-3 cells treated respectively with *Ormenis eriolepis* Dichloromethane Fraction (Oe-DF) and Hexanic Extract (Oe-HE) by flow cytometry. Jurkat, Jeko-1, LN229 and PC-3 cells were incubated respectively with 20 μg/ml and 50 μg/ml of Oe-DF and Oe-HE for 24h and 48h. Cells were harvested and their DNA content analysed by flow cytometry as described in Materials and Methods. The cell cycle distribution is shown for each experimental condition.](AJTCAM-14-356-g003){#F3}

Next, we analyzed the presence of DNA damage by monitoring p-H2A.X levels to investigate the possible molecular mechanism of *Ormenis eriolepis*. As shown in [Figure 4](#F4){ref-type="fig"}, increased levels of p-H2A.X were detected in Oe-DF treated cells (jurkat and jeko-1) as well as in Oe-HE treated cells (LN229 and PC-3) after 6h to 12h of treatement. These results suggest that both the Dichloromethane Fraction and Hexanic extract induce DNA double stranded breaks (DSBs) accompanied by cell cycle arrest in G1 (Jurkat, Jeko-1 and LN22) and G2/M (PC-3) phases.

![Effect of Oe-DF and Oe-HE on p-H2AX expression levels in Jurkat, Jeko-1, LN229 and PC-3 cells. Cells (4 × 10cells /ml) were treated respectively with 20 μg/ml and 50 μg/ml of Oe-DF and Oe-HE for 0, 6 and 12h. p-H2A.X levels in cellular extracts were detected by immunoblot with specific antibodies. Tubulin was used as an internal control.](AJTCAM-14-356-g004){#F4}

Effect of Ormenis eriolepis organic extracts on apoptosis induction and caspases activation. {#sec2-15}
--------------------------------------------------------------------------------------------

Double Annexin V/Propidium Iodide staining was performed to analyze and quantify cellular death. Upon exposure to treatment, an increase in the number of Annexin V positive cells was observed for both Oe-DF and Oe-HE as shown in [Figure 5](#F5){ref-type="fig"}. For Jurkat and Jeko-1 cells, a percentage of (11% and 27,9%) was observed at 12h of Oe-DF exposure. where LN229 and PC-3 cells have shown an increase of apoptotic cell population of (24% and 20,4%) as well after 12h of treatment.

![Effect of (Oe-DF) in Jurkat and Jeko-1 cell and (Oe-HE) in LN229 and PC-3 on apoptosis induction analyzed by flow cytometry. Jurkat, Jeko-1, LN229 and PC-3 cells were incubated respectively with 20 μg/ml and 50 μg/ml of Oe-DF and Oe-HE for 12h and 24h. The x-axis shows Annexin V-FITC staining and y-axis indicates Propidium iodide staining; Lower left (LL) quadrant: viable cells; lower right (LR) quadrant: early apoptotic cells; upper left (UL) quadrant: necrotic cells, upper right (UR) quadrant: late apoptotic cells.](AJTCAM-14-356-g005){#F5}

Different caspases are activated as a crucial biochemical event during apoptosis. To investigate if *Ormenis eriolepis* induced apoptosis in Jurkat, Jeko-1, LN229 and PC-3 cell lines is caspases dependent, we performed caspase 3/7 activity assays upon treatment of (Jurkat and Jeko-1) cells with 20μg/ml of Oe-DF and (LN229 and PC-3) cells with 50μg/ml of Oe-HE for 48h. [Figure 6](#F6){ref-type="fig"} prove that both treatments increased caspase activity to 8 and 14 fold up in jurkat and jeko-1 cells, while Oe-HE increased similarly the caspase activity to 4 fold up in both LN229 and PC-3 cells upon 48h of exposure. Accordingly, this data may suggest that *Ormenis eriolepis* induced cell death includes caspases activation.

![Effect of *Ormenis eriolepis* Fraction and Extract on caspase activity induction on Jurkat, Jeko-1, LN229 and PC-3 cells. **(A)** Jurkat and Jeko-1 cells were treated with 20 μg/ml of (Oe-DF) for 48h and caspase activity was measured **(B)** LN229 and PC-3 cells were treated with 50 μg/ml of (Oe-HE) for 48h and caspase activity was measured. Results indicate the average fold increase ± S.E.M in caspase activity relative to untreated cells from three independent determinations performed in duplicate.](AJTCAM-14-356-g006){#F6}

Effect of Ormenis eriolepis organic extracts on stress and survival cell pathways. {#sec2-16}
----------------------------------------------------------------------------------

As a preliminary investigation of the molecular mechanism of *Ormenis eriolepis* induced apoptosis, we analyzed additional experiments with a panel of selective inhibitors of stress and survival pathways (SP600125, U0126, H1152, Pifithrin α and JAK3) performed in (Jurkat and Jeko-1) ([figure 7A](#F7){ref-type="fig"}) and (LN229 and PC-3) ([Figure 7B](#F7){ref-type="fig"}) cells upon Oe-DF and Oe-HE treatments at 48h. The results showed that none of these pathways was significantly involved in *Ormenis eriolepis* induced cell death and that neither JNK, ERK1/2, Rho, p53 nor JAK3 pathways seems involved. Taken together, this results shows that more molecular investigation is needed to figure out the apoptotic signaling regulators responsible of *Ormenis eriolepis* anti tumoral effect in Jurkat, Jeko-1, LN229 and PC-3 cell lines.

![Effect of *Ormenis eriolepis* Fraction and Extract on the viability of Jurkat, Jeko-1, LN229 and PC-3 cells in presence of a panel of signaling pathways inhibitors. **(A)** Jurkat and Jeko-1 **(B)** LN229 and PC-3 cells were untreated or treated respectively with 20 and 50 μg/ml of Oe-DF and Oe-HE in the presence or absence of SP600125, U0126; H1152, Pifithrin or Jak3 inhibitor (all at 10 μM) for 48h. Inhibitors were pre-incubated for 1 hour before the addition of Mv-DF extract. Cell viability is represented as a percentage relative to untreated cells. Data is means ± S.E.M from three independent determinations performed in duplicate.](AJTCAM-14-356-g007){#F7}

Characterization of chemical compounds in Ormenis eriolepis Dichloromethane Fraction and Hexane Extract. {#sec2-17}
--------------------------------------------------------------------------------------------------------

In order to recognize the bioactive compounds responsible for these effects, Oe-DF and Oe-HE were subjected to GC-MS analysis and compounds were identified using mass spectrometry ([Figure 8A](#F8){ref-type="fig"} and [8B](#F8){ref-type="fig"}).

![**(A) Chromatogram of *Ormenis eriolepis* Dichloromethane Fraction obtained by CG.** Compounds were identified by computer searches in the reference libraries of NIST and Wiley7, and fragmentation patterns were compared with literature Data. Oe-DF constituents are shown in [Table 1](#T1){ref-type="table"}. **(B) Chromatogram of *Ormenis eriolepis* Hexanic Extract obtained by CG.** Oe-HE constituents are shown in [Table 2](#T2){ref-type="table"}.](AJTCAM-14-356-g008){#F8}

Retention time, Cas Numbers and % of identified area are summarized in [Table 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}. The mass spectra compounds were matched with computer searches in the references libraries of NIST08 and Wiley 7, and fragmentation patterns were compared with literature and commercially available products data. The major bioactive compounds identified in Oe-DF ([Figure 9A](#F9){ref-type="fig"}) were: Linoleic Acid (15,89%), Podophyllotoxin (17,89%) and Quercetin (22,95%). In Oe-HE ([Figure 9B](#F9){ref-type="fig"}) the major molecules were: Linoleic Acid (9,76%), α-curcumene (7,07%), α-bisabolol (5,49%), Campesterol (4,41%), Stigmasterol (14,08%) and β-sitosterol (7,49%).

###### 

Compounds present in dichloromethane fraction of Ormenis eiriolepis identified by CG/MS.

  RT           identified compounds                                                                  cas numbers   \% Area
  ------------ ------------------------------------------------------------------------------------- ------------- ----------
  **15,877**   Propanoic acid,2-\[(trimethylsilyl)oxy\]-, trimethylsilyl ester                       17596-96-2    0,19604
  **16,449**   Glycolic acid, TMS                                                                    33581-77-0    0,176436
  **16,748**   2-(Trimethylsiloxy)propenoic acid trimethylsilyl ester                                55191-13-4    0,19604
  **21,671**   Silanol, 1,1,1 -trimethyl-, 1 -benzoate                                               08/12/2078    0,470496
  **22,147**   Octanoic acid, trimethylsilyl ester                                                   55494-06-9    0,137228
  **23,091**   Phenylacetoxytrimethylsilane                                                          2078-18-4     0,352872
  **23,531**   Butanedioic acid, bis(trimethylsilyl) ester                                           40309-57-7    0,431288
  **23,877**   Glyceric acid (3TMS)                                                                  38191-87-6    0,09802
  **24,787**   Nonanoic acid trimethylsilyl ester                                                    82326-11-2    0,176436
  **25,247**   Benzaldehyde, p-(trimethylsiloxy)-(7CI,8CI)                                           1012-12-0     0,058812
  **27,294**   Decanoic acid, trimethylsilyl ester                                                   55494-15-0    0,235248
  **27,695**   4'-(Trimethylsilyloxy)acetophenone                                                    18803-29-7    0,470496
  **27,988**   malatate                                                                              65143-63-7    0,29406
  **29,26**    Trimethylsilylvanillin                                                                6689-43-6     0,176436
  **29,441**   (S)-dihydroactinidiolide                                                              17092-92-1    0,842972
  **30,245**   a-\[(Trimethylsilyl)oxy\]benzenepropionic acid trimethylsilyl ester                   27750-45-4    0,09802
  **31,336**   Benzoic acid,4-\[(trimethylsilyl)oxy\]-, trimethylsilyl ester                         2078-13-9     0,646932
  **31,889**   4-Methoxy-3-(trimethylsiloxy)benzoic acid methyl ester                                55590-91-5    0,548912
  **33,343**   Benzoic acid, 3,4-bis\[(trimethylsilyl)oxy\]-, methyl ester                           27798-58-9    1,137032
  **35,023**   Nonanedioic acid bis(trimethylsilyl) ester                                            17906-08-0    2,019212
  **35,433**   Protocatechuic acid, di-TMS                                                           2347-40-2     0,999804
  **35,098**   Tetradecanoic acid trimethylsilyl ester                                               18603-17-3    1,097824
  **36,994**   3 -Methoxy-4-\[(trimethylsilyl)oxy\]benzenepropionic acid trimethylsilyl ester        56051-49-1    0,823368
  **37,06**    Benzoic acid,3,5-dimethoxy-4-\[(trimethylsilyl)oxy\]-, trimethylsilyl ester           10517-29-0    0,9802
  **37,919**   3-\[3-\[(Trimethylsilyl)oxy\]phenyl\]propenoic acid trimethylsilyl ester              32342-01-1    0,999804
  **38,883**   1,11-Undecanedioic acid, di(trimethylsilyl) ester                                     106450-25-3   0,842972
  **39,199**   3-\[3,4-Bis(trimethylsilyloxy)phenyl\]propenoic acid methyl ester                     22020-29-7    2,372084
  **41,57**    2-Propenoic acid, 3-\[3,4-bis\[(trimethylsilyl)oxy\]phenyl\]-, trimethylsilyl ester   10586-03-5    1,86238
  **42,53**    ALMITIC ACID N-BUTYL ESTER                                                            111-06-8      1,431092
  **42,91**    Linoleic acid trimethylsilyl                                                          56259-07-5    15,89884
  **43,458**   Octadecanoic acid, trimethylsilyl ester                                               18748-91-9    4,901
  **46,698**   Eicosanoic acid, trimethylsilyl ester                                                 55530-70-6    2,078024
  **48,896**   Hexadecanoic acid 2,3-bis\[(trimethylsilyl)oxy\]propyl ester                          1188-74-5     8,586552
  **49,699**   Docosanoic acid trimethylsilyl ester                                                  74367-36-5    2,920996
  **51,665**   Stearic acid 2,3-bis(trimethylsilyloxy)propyl ester                                   1188-75-6     4,587336
  **55,302**   Podophyllotoxin                                                                       518-28-5      17,89845
  **56,24**    Quercetin, penta-TMS                                                                  4067-66-7     22,95824

###### 

Compounds present in the hexanic extarct of Ormenis eiriolepis identified by CG/MS

  RT           identified compounds                                           cas numbers   \% Area
  ------------ -------------------------------------------------------------- ------------- ------------
  **15,879**   2-(Trimethylsiloxy)propanoic acid trimethylsilyl ester         17596-96-2    0,14554795
  **16,377**   Hexanoic acid, trimethylsilyl ester                            14246-15-2    0,06849315
  **16,453**   Glycolic acid, bis-TMS                                         33581-77-0    0,08561644
  **22,162**   Octanoic acid, trimethylsilyl ester                            55494-06-9    0,08561644
  **24,802**   Nonanoic acid trimethylsilyl ester                             82326-11-2    0,11986301
  **27,301**   Decanoic acid, trimethylsilyl ester                            55494-15-0    0,65924658
  **28,018**   alpha-curcumene                                                644-30-4      7,07191781
  **28,697**   (+) -aromadendrene                                             489-39-4      0,72773973
  **29,368**   (S)-dihydroactinidiolide                                       17092-92-1    0,10273973
  **32,891**   alpha-Bisabolol                                                515-69-5      5,49657534
  **35,032**   Nonanedioic acid bis(trimethylsilyl) ester                     17906-08-0    0,39383562
  **36,112**   Tetradecanoic acid trimethylsilyl ester                        18603-17-3    0,65924658
  **39,968**   Hexadecanoic acid, trimethylsilyl ester                        55520-89-3    4,29794521
  **41,732**   Heptadecanoic acid, trimethylsilyl ester                       55517-58-3    0,64212329
  **42,728**   1,2-Hexadecanediol                                             6920-24-7     0,59075342
  **42,949**   Linoleic acid trimethylsilyl                                   56259-07-5    9,76883562
  **43,096**   alpha-Linolenic acid, trimethylsilyl ester                     97844-13-8    15,3424658
  **43,467**   Octadecanoic acid, trimethylsilyl ester                        18748-91-9    2,43150685
  **46,707**   Eicosanoic acid, trimethylsilyl ester                          55530-70-6    1,27568493
  **48,372**   1-Docosanol                                                    661-19-8      6,59246575
  **48,897**   Hexadecanoic acid 2,3-bis\[(trimethylsilyl)oxy\]propyl ester   1188-74-5     3,3989726
  **49,711**   Docosanoic acid trimethylsilyl ester                           74367-36-5    2,40582192
  **51,26**    1-TETRACOSANOL                                                 506-51-4      7,32020548
  **54,002**   Icosanoic acid 2,3-bis(trimethylsilyloxy)propyl ester          55517-94-7    1,54109589
  **54,638**   Hexacosanoic Acid                                              506-46-7      2,66267123
  **57,21**    CAMPESTEROL                                                    474-62-4      4,41780822
  **57,567**   Stigmasterol trimethylsilyl ether                              14030-29-6    14,0839041
  **58,444**   β-Sitosteryl trimethylsilyl ether                              2625-46-9     7,49143836

![(A) Chemical structures of the major bioactive compounds of *Ormenis eriolepis* Dichloromethane Fraction. (B) Chemical structures of the major bioactive compounds of *Ormenis eriolepis* Hexanic Extract.](AJTCAM-14-356-g009){#F9}

Discussion {#sec1-4}
==========

After the rapid expansion of the use of monoclonal antibodies and various synthetic inhibitors directed against matrix metalloproteases or protein kinases, natural products are regaining attention in the oncology field. Due to their wide range of biological activities and low toxicity in animal models, natural products have been used as alternative treatments for cancers (Newman and Cragg 2012). Several drugs currently used in chemotherapy were isolated from plant species. The best known are the Vinca alkaloids, vinblastine and vincristine, isolated from Catharanthus roseus, etoposide and teniposide, which are semi-synthetic derivatives of the natural product epipodophyllotoxin, Paclitaxel isolated from the barkof Taxus brevifolia, the semi-synthetic derivatives of camptothecin, irinotecan and topotecan, isolated from Camptotheca acuminata, among several others (Cragg *et al.*, 1993)

All Cancer cells are characterized by unregulated growth, as well as insufficient and inappropriate vascular supply (Tomida and Tsuruo, 1999).

T-cell lymphoblastic leukemia (Jurkat), Mantle cell lymphoma (Jeko-1), Glioblastoma multiforme (LN229) and Prostate Cancer (PC-3) are cell lines models for aggressive neoplastic disorders; they are known to have alteration in multiple cellular pathways including apoptosis. Deficiencies in this last, contribute to carcinogenesis by creating a permissive environment for genetic instability and accumulation of gene mutations conferring resistance to cytotoxic anticancer drugs and radiation (Irwin *et* al.;2013).

*Ormenis eriolepis Coss* (Asteraceae) an endemic Moroccan subspecies, traditionally named "Hellala" or "Fergoga" used for its hypoglycemic effect as well as for the treatment of stomacal pain. As far as we know, there is no scientific exploration of the anti-tumor capacity of *Ormenis eriolepis* extracts. In this study, we present the first evidence of tumor cell growth inhibitory activity of Oe-DF and Oe-HE by using in vitro experimental models. We show that both organic extract decreased specifically the viability of Jurkat, Jeko-1, LN229 and PC-3 cell lines in a dose specific manner, while it did not affect non-transformed human lymphocyte and mice fibroblasts TK-6 and NIH3T3.

Disturbance of the cancer cell cycle is one of the therapeutic targets for development of new anticancer drugs (Carnero; 2002). Analytical results indicate that Oe-DF have effectively reduced the proportion of S-phase cells while strongly increased the proportion of Sub G1 cells. Whereas Oe-HE in LN229 cells mainly exerts a combination of G1 arrest and sub-G1 increase at 24h, with this latter population further increasing at 48h up. In PC-3 cells Oe-HE induced a clear G2/M arrest which was already detectable at 24h. Therefore, a mechanism inducing cell cycle arrest and senescence can be triggered by damage on DNA (Ben-Porath and Weinberg, 2005; Maruyama *et al.*, 2009). The occurrence of phosphorylation on histone H2AX, namely y-H2AX, has been widely used as a sensitive marker of DNA damage. Both Oe-DF and Oe-HE increased y-H2AX levels after 6h to 12h of treatment. Clearly, more specific studies are needed to investigate how Oe-DF and Oe-HE affect key proteins involved in cell cycle control in the four sensitive cell lines, namely P53, P16, P21, Cyclin dependant kinase and cyclins. Therefore, these findings point to the cycle arrest is being caused by a sophisticated mechanism in which the actions are initiated by DNA double stranded breaks.

The process of programmed cell death, or apoptosis is an important homeostatic mechanism that balances cell division and cell death to maintain appropriate cell number in tissues (Elmore; 2007). Flow cytometry analysis upon Annexin-V/propidium iodide staining detects and quantifies the amount of cells undergoing apoptosis. Up on exposure to treatment, an increase in the number of Annexin V positive cells was observed for both Oe-DF and Oe-HE in Jurkat and Jeko-1 cells, LN229 and PC-3 cells respectively in a time-dependent manner, demonstrating that *Ormenis eriolepis* induces cell death through the promotion of apoptosis.

Apoptosis signal transduction and execution require the coordinated action of the cascade of caspases (asparate-specific cysteine proteases). Caspases are expressed as inactive proenzymes and become activated by proteolytic processing at internal aspartate residues when cells receive an apoptosis-inducing signal. At present 14 mammalian caspase family members have been described. Some, including caspases-2, -8, -9 and -10 are initiators of cell death (contain large prodomains). Once activated, these initiator caspases in turn activate the executioner caspases such as caspases-3, -6 and -7 (carry small prodomains). Thus, caspases can activate each other (Takahashi, 1998). For this purpose, we determined if the enzymatic activity of caspase 3 and 7 was increased in Jurkat and Jeko-1 under Oe-DF treatment, as well as LN229 and PC-3 under Oe-HE. Data shows, that both treatments increased caspase activity upon 48h of exposure. Which may suggest that *Ormenis eriolepis* induced cell death may include caspases activation.

Apoptosis can be mediated by several pathways that may involve complex molecular interactions and biochemical regulators. As a very preliminary investigation, we analyzed the effect of a panel of stress and survival pathways inhibitors in Jurkat, Jeko-1, LN229 and PC-3 cell lines under their respective *Ormenis eriolepis* treatment. For this regard, JNK inhibitor SP600125, the MEK inhibitor U0126, the Rho inhibitor H1152, the p53 inhibitor pifithrin α and the JAK3 inhibitor were used. As shown, none of these inhibitors protected the studied cell lines from *Ormenis eriolepis* induced cell death. However, further detailed investigations are needed to elucidate the mechanism of action in Jurkat, Jeko-1, LN229 and PC-3 cells in order to obtain definite conclusions.

In this study, GC-MS analysis was conducted on both Oe-DF and Oe-HE in order to recognize the bioactive compounds responsible for these effects. The major bioactive compounds identified in Oe-DF were: Linoleic Acid (15,89%), Podophyllotoxin (17,89%) and Quercetin (22,95%). In Oe-HE the major molecules were: Linoleic Acid (9,76%), α-curcumene (7,07%), α-bisabolol (5,49%), Campesterol (4,41%), Stigmasterol (14,08%) and β-sitosterol (7,49%).

Remarkably, all these identified compounds are known for their cytotoxic activity against cancer cells. Podophyllotoxin, it is effective in the treatment of Wilms tumours, different types of genital tumors (carcinoma verrucosus, for example) and in non-Hodgkin and other lymphomas (Ayres and Loike, 1990) and lung cancer (Utsugi et al., 1996; Subrahmanyam et al., 1998). Three semisynthetic derivatives of podophyllotoxin, etoposide, teniposide and etopophos, were widely used as anticancer drugs and show good clinical effects against several types of neoplasms including testicular and small-cell lung cancers, lymphoma, leukaemia, Kaposi's sarcoma, etc (Ayres and Loike, 1990).

Numerous studies have described the cancer preventive effects and molecular mechanisms of quercetin, which has been shown to one of the major flavonoids with antiproliferative efficacy on a wide range of cancer cells (Boyer et al., 2004; Kang and Liang, 1997; Suh et al., 2010). For example, quercetin was shown to inhibit the growth of acute lymphoid and myeloid leukemia cells (Kang and Liang, 1997). It was also reported to have growth-inhibitory effects on human gastric and colon cancer cells by inhibiting cell cycle progression at the G1 -S boundary (Suh et al., 2010). These diverse antitumor activities of quercetin make it a lead compound for the development of new effective cancer preventive or therapeutic agents. α-bisabolol is a small oily sesquiterpene alcohol that has been demonstrated to have activity against some malignant adherent human and rat cell lines and against spontaneous mammary tumors in HER-2 transgenic mice as well as in HepG2 and Glioma cells (Costarelli *et al*. 2010;. Darra *et al.;* 2008; Chen *et al.;* 2010).

Campesterol, β-sitosterol and stigmasterol displayed remarkable cytotoxic activity against A549 cells. These in vitro data support findings that a mixture consisting of these three sterols exerted cytotoxic activity against cancer cells (Lai *et al.*, 2010). Notably, β-sitosterol induced G2/M arrest, endoreduplication, and apoptosis on U937 lymphoma cells and HL60 promyelocytic leukemic cells through the Bcl-2 and PI3K/Akt signaling pathways (Moon *et al.*, 2008). Stigmasterol maintained a non-dose-responsive inhibition of growth (around 40-50% inhibition between 1.6 and 50 μg/ml) of HS578T breast cancer cells (Lai *et al.*, 2010).

Conclusions {#sec1-5}
===========

Our study findings support the notion that *Ormenis eriolepis* have a combination of several bioactive compounds that can be responsible either alone or together for its outstanding antitumor activity and also the chemoprevention proprieties that can have the plant decoction if used regularly in healthy diet, brings a clear scientific support to the use of Moroccan medicinal plants by traditional healers for the treatment of cancer patients. Fi nally and as preliminary information, it opens the way for further investigations to elucidate the possible molecular mechanisms involved in cancer cell death and cell cycle arrest.
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